River Edge, NJ, United States of America

Anupama K Nadkarni


Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Anupama K Nadkarni: Innovator in G Protein-Coupled Receptor Research

Introduction

Anupama K Nadkarni is a prominent inventor based in River Edge, NJ (US). She has made significant contributions to the field of pharmacology through her innovative research on G protein-coupled receptors. Her work focuses on the expression and modification of these receptors, which play a crucial role in cellular communication and drug development.

Latest Patents

Anupama holds a patent for the "Expression of G protein-coupled receptors with altered ligand binding and/or coupling properties." This patent describes modified forms of G protein-coupled receptors that exhibit altered ligand binding and/or coupling properties. The invention includes cells expressing these receptors and assays that utilize these cells for screening and identifying pharmaceutically effective compounds. The assays enable rapid screening of large numbers of compounds to identify receptor agonists or antagonists. The novel receptors, recombinant yeast cells, and gene constructs provided in this patent offer a convenient format for discovering compounds that can modulate cellular function.

Career Highlights

Anupama K Nadkarni has been associated with Cadus Technologies, Inc., where she has contributed her expertise in receptor research. Her work has been instrumental in advancing the understanding of pharmacology related to G protein-coupled receptors.

Collaborations

Anupama collaborates with Joshua Trueheart, enhancing the research efforts at Cadus Technologies, Inc. Their combined expertise fosters innovation in the field of receptor pharmacology.

Conclusion

Anupama K Nadkarni's contributions to the field of G protein-coupled receptors exemplify her dedication to advancing pharmaceutical research. Her innovative patent and collaborative efforts continue to impact the understanding of cellular functions and drug interactions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…